BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 12, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, May 12, 2025 -- Bacille Calmette-Guérin (BCG) revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection, defined by sustained QuantiFERON-TB (QFT) test conversion, according to a study published in the May 8 issue of the New England Journal of Medicine.

Alexander C. Schmidt, M.D., from the Gates Medical Research Institute in Cambridge, Massachusetts, and colleagues conducted a phase 2b, double-blind, randomized trial to examine the efficacy of BCG revaccination compared with placebo for the prevention of sustained QFT test conversion in QFT test-negative HIV-negative adolescents. A secondary analysis assessed adverse events, while immunogenicity was assessed in an exploratory analysis. The trial included 1,836 participants: 918 were randomly allocated to receive the BCG vaccine and 917 to receive placebo.

The researchers observed a sustained QFT conversion in 62 of 871 and 59 of 849 participants in the BCG-vaccine and placebo groups, respectively, after 30 months, with a hazard ratio of 1.04 (95 percent confidence interval, 0.73 to 1.48) and vaccine efficacy point estimate of −3.8 percent (95 percent confidence interval, −48.3 to 27.4). Compared with the placebo group, adverse events occurred more often in the BCG-vaccine group, and most were due to injection-site reactions. Cytokine-positive type 1 helper CD4 T cells were induced by BCG revaccination.

"Although this trial does not allow us to draw firm conclusions on the efficacy of BCG revaccination for the prevention of disease, the lack of vaccine efficacy with respect to prevention of infection probably decreases the likelihood of BCG revaccination conferring protection against disease," the authors write.

Several authors disclosed ties to the pharmaceutical and other industries; one author holds related patents.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-13 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords